This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


4zw8

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:25, 27 September 2023) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 1: Line 1:
==X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9r==
==X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9r==
-
<StructureSection load='4zw8' size='340' side='right' caption='[[4zw8]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
+
<StructureSection load='4zw8' size='340' side='right'caption='[[4zw8]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4zw8]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZW8 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZW8 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4zw8]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Plasmodium_falciparum_FcB1/Columbia Plasmodium falciparum FcB1/Columbia]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZW8 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4ZW8 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4T2:TERT-BUTYL+{(1S)-2-(HYDROXYAMINO)-1-[3-(N-HYDROXYCARBAMIMIDOYL)BIPHENYL-4-YL]-2-OXOETHYL}CARBAMATE'>4T2</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3ebg|3ebg]], [[4zw3|4zw3]], [[4zw5|4zw5]], [[4zw6|4zw6]], [[4zw7|4zw7]], [[4zx3|4zx3]], [[4zx4|4zx4]], [[4zx5|4zx5]], [[4zx6|4zx6]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=4T2:TERT-BUTYL+{(1S)-2-(HYDROXYAMINO)-1-[3-(N-HYDROXYCARBAMIMIDOYL)BIPHENYL-4-YL]-2-OXOETHYL}CARBAMATE'>4T2</scene>, <scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4zw8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zw8 OCA], [http://pdbe.org/4zw8 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4zw8 RCSB], [http://www.ebi.ac.uk/pdbsum/4zw8 PDBsum]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4zw8 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zw8 OCA], [https://pdbe.org/4zw8 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4zw8 RCSB], [https://www.ebi.ac.uk/pdbsum/4zw8 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4zw8 ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/AMP1_PLAFQ AMP1_PLAFQ]] Displays aminopeptidase activity with a broad substrate specificity. Preferentially hydrolyzes L-Lys-AMC but also shows strong activity against L-Ala-AMC, L-Arg-AMC and L-Leu-AMC.<ref>PMID:12166515</ref> <ref>PMID:19196988</ref>
+
[https://www.uniprot.org/uniprot/AMP1_PLAFQ AMP1_PLAFQ] Displays aminopeptidase activity with a broad substrate specificity. Preferentially hydrolyzes L-Lys-AMC but also shows strong activity against L-Ala-AMC, L-Arg-AMC and L-Leu-AMC.<ref>PMID:12166515</ref> <ref>PMID:19196988</ref>
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 19: Line 19:
</div>
</div>
<div class="pdbe-citations 4zw8" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 4zw8" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[Aminopeptidase 3D structures|Aminopeptidase 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Drinkwater, N]]
+
[[Category: Large Structures]]
-
[[Category: McGowan, S]]
+
[[Category: Plasmodium falciparum FcB1/Columbia]]
-
[[Category: Hydrolase-hydrolase inhibitor complex]]
+
[[Category: Drinkwater N]]
-
[[Category: Hydroxamic acid]]
+
[[Category: McGowan S]]
-
[[Category: Inhibitor]]
+
-
[[Category: M1 alanyl-aminopeptidase]]
+
-
[[Category: Protease]]
+

Current revision

X-ray crystal structure of PfA-M1 in complex with hydroxamic acid-based inhibitor 9r

PDB ID 4zw8

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4zw8"
Personal tools